AG

Anta Gkelou

Partner at Sofinnova Partners

Paris, Île-de-France

Invests in

Sectors:

Locations:

  • Min Investment:

    $100,000.00
  • Max Investment:

    $5,000,000.00
  • Target Investment:

    $1,500,000.00

Work Experience

  • Partner

    2024

  • Principal

    2020 - 2024

  • Associate

    2017 - 2020

  • Board Observer

    2020

2021 - 2024

  • Member Board Of Directors -35

    2021 - 2024

  • Board Observer

    2020 - 2024

2020 - 2024

  • Board Observer

    2020 - 2024

  • Immunology Scientist

    2016 - 2017

  • Postdoctoral Fellow

    2015 - 2016

    Vascularisation in Alzheimer's disease

2013 - 2016

  • Postdoctoral Fellow

    2013 - 2016

    Paris centre of cardiovascular research, PARCC- INSERM U970 Key areas of research: Immunology: The role of mast cells in cardiac function following myocardial infartcion; The role of CXCL12/CXCR4 interactions in regulating cardiac remodeling following myocardial infarction, under the supervision of Dr. Jean-Sebastien Silvestre

  • Clinical Medical research, CASE studentship with Pfizer

    2008 - 2012